61
https://pubmed.ncbi.nlm.nih.gov/38116435
The abstract reports the repurposing of the azole antifungal Clotrimazole as a potential treatment for drug-resistant tuberculosis, showing equipotent activity against the Mtb H37Rv strain compared to Linezolid, but with significantly less inhibition of monoamine oxidase (MAO) enzymes, suggesting a reduced serotonergic toxicity burden.
